PRAX
Praxis Precision Medicines, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth -15.4% ·
share flow +13.6% ·
net new positions -18.2%
— formula
Concentrated accumulation — rising shares among fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 111 | +10 | 16.57M | $5.55B | +16 | −5 |
| Q1 2026 | 103 | +2 | 17.55M | $5.65B | +11 | −10 |
| Q4 2025 | 101 | +1 | 18.04M | $5.32B | +2 | — |
| Q3 2025 | 17 | +1 | 10.82M | $573.60M | +1 | −1 |
| Q2 2025 | 14 | 0 | 8.51M | $357.72M | +1 | −1 |
| Q1 2025 | 11 | -2 | 4.62M | $175.13M | — | −2 |
| Q4 2024 | 13 | 0 | 4.07M | $313.25M | — | — |
| Q3 2024 | 12 | 0 | 3.95M | $227.16M | +1 | −1 |
| Q2 2024 | 12 | — | 4.09M | $168.97M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Adage Capital Partners ✦ | 1.74M | +188.1% | $66.00M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 1.10M | -9.3% | $41.50M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 1.10M | -9.3% | $41.50M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 4 | State Street Global Advisors ✦ (passive) | 737.04K | -4.1% | $27.91M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passive) | 418.02K | +2.8% | $15.83M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Geode Capital Management ✦ (passive) | 418.02K | +2.8% | $15.83M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | Point72 Asset Management ✦ | 333.53K | -36.0% | $12.63M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 8 | Norges Bank ✦ (passive) | 84.20K | -29.2% | $3.19M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 9 | Millennium Management ✦ | 69.18K | -54.1% | $2.62M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 62.21K | -33.2% | $2.36M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 11 | Wellington Management ✦ | 50.78K | -20.6% | $1.92M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 12 | Wellington Management ✦ | 50.78K | -20.6% | $1.92M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 13 | Two Sigma Investments ✦ | 18.81K | -6.3% | $712,259 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 14 | D. E. Shaw & Co. ✦ | 12.21K | -74.6% | $462,317 | 0.0% | ▼ Trim | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Marshall Wace | $4.49M | was 0.0% |
| AQR Capital Management | $515,940 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 287 holders, 28.34M shares, $8.85B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.